Safety and efficacy of Lomecel‐B in patients with mild Alzheimer’s disease: Results of a double‐blinded, randomized, placebo‐controlled phase 1 clinical trial

Anthony A. Oliva; Mark Brody; Marc Agronin; Brad Herskowitz; Susan Y Bookheimer; Ben Hitchinson; Kevin Ramdas; Tyler Wishard; Lisa McClain‐Moss; Liliana A. Diaz; Keyvan Yousefi; Carmen Perez; Ana Fuquay; Savannah Rodriguez; Joshua M. Hare; Bernard Baumel

doi:10.1002/alz.057581

Safety and efficacy of Lomecel‐B in patients with mild Alzheimer’s disease: Results of a double‐blinded, randomized, placebo‐controlled phase 1 clinical trial

Alzheimer s & Dementia ◽

10.1002/alz.057581 ◽

2021 ◽

Vol 17 (S9) ◽

Author(s):

Anthony A. Oliva ◽

Mark Brody ◽

Marc Agronin ◽

Brad Herskowitz ◽

Susan Y Bookheimer ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Clinical Trial ◽

Phase 1 ◽

Safety And Efficacy ◽

Phase 1 Clinical Trial ◽

Double Blinded

Download Full-text

Analyses of a Phase 1 Clinical Trial of Adeno- associated Virus-Nerve Growth Factor (CERE-110) Gene Therapy in Alzheimer's Disease

Neurosurgery ◽

10.1227/01.neu.0000279944.12903.2c ◽

2007 ◽

Vol 61 (1) ◽

pp. 216-216 ◽

Cited By ~ 4

Author(s):

Roy A.E. Bakay ◽

Zoe Arvanitakis ◽

Mark Tuszynski ◽

Steve Potkin ◽

Ray Bartus ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Clinical Trial ◽

Gene Therapy ◽

Nerve Growth Factor ◽

Growth Factor ◽

Phase 1 ◽

Adeno Associated Virus ◽

Nerve Growth ◽

Phase 1 Clinical Trial

Download Full-text

A phase 1 clinical trial of the sigma‐2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease

Alzheimer s & Dementia Translational Research & Clinical Interventions ◽

10.1016/j.trci.2018.11.001 ◽

2018 ◽

Vol 5 (1) ◽

pp. 20-26 ◽

Cited By ~ 11

Author(s):

Michael Grundman ◽

Roger Morgan ◽

Jason D. Lickliter ◽

Lon S. Schneider ◽

Steven DeKosky ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Clinical Trial ◽

Phase 1 ◽

Receptor Complex ◽

Phase 1 Clinical Trial ◽

Novel Therapeutic

Download Full-text

Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077

British Journal of Haematology ◽

10.1111/bjh.12361 ◽

2013 ◽

Vol 162 (2) ◽

pp. 202-209 ◽

Cited By ~ 24

Author(s):

Wolfram Pönisch ◽

Simone Heyn ◽

Juliane Beck ◽

Ina Wagner ◽

Martin Mohren ◽

...

Keyword(s):

Clinical Trial ◽

Multiple Myeloma ◽

Phase 1 ◽

Safety And Efficacy ◽

Phase 1 Clinical Trial ◽

Refractory Multiple Myeloma ◽

Favourable Safety ◽

Efficacy Profile

Download Full-text

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease

Case Medical Research ◽

10.31525/ct1-nct04228666 ◽

2020 ◽

Author(s):

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Clinical Trial ◽

Stem Cell ◽

Mesenchymal Stem Cell ◽

Cell Therapy ◽

Stem Cell Therapy ◽

Safety And Efficacy ◽

Mesenchymal Stem Cell Therapy

Download Full-text

Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial

The Journal of Infectious Diseases ◽

10.1093/infdis/jiv179 ◽

2015 ◽

Vol 212 (7) ◽

pp. 1032-1041 ◽

Cited By ~ 48

Author(s):

Sarah L. George ◽

Mimi A. Wong ◽

Tina J. T. Dube ◽

Karen L. Boroughs ◽

Janae L. Stovall ◽

...

Keyword(s):

Clinical Trial ◽

Vaccine Candidate ◽

Phase 1 ◽

Dengue Vaccine ◽

Phase 1 Clinical Trial ◽

Double Blinded

Download Full-text

Faculty Opinions recommendation of Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717948811.793453912 ◽

2012 ◽

Author(s):

Rachita Dhurat ◽

Sukesh M.S

Keyword(s):

Clinical Trial ◽

Phase 1 ◽

Safety And Efficacy ◽

Phase 1 Clinical Trial ◽

Hair Regrowth ◽

Treatment Safety

Download Full-text

P3-272: A COMPARISON OF EEG CONNECTIVITY OUTCOME MEASURES FOR ALZHEIMER'S DISEASE IN A DOUBLE-BLINDED RANDOMIZED CLINICAL TRIAL OF PQ912

Alzheimer s & Dementia ◽

10.1016/j.jalz.2018.06.1632 ◽

2006 ◽

Vol 14 (7S_Part_22) ◽

pp. P1181-P1182

Author(s):

Casper T. Briels ◽

Cornelis J. Stam ◽

Philip Scheltens ◽

Alida A. Gouw

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Outcome Measures ◽

Eeg Connectivity ◽

Double Blinded

Download Full-text

A phase 1 clinical trial evaluating the safety and efficacy of up to two administrations of the adrenal PET tracer [18F]CETO in healthy volunteers and patients with primary aldosteronism

Endocrine Abstracts ◽

10.1530/endoabs.77.op2.1 ◽

2021 ◽

Author(s):

Russell Senanayake ◽

Daniel Gillett ◽

Waiel Bashari ◽

James MacFarlane ◽

Lihua Hu ◽

...

Keyword(s):

Clinical Trial ◽

Healthy Volunteers ◽

Primary Aldosteronism ◽

Phase 1 ◽

Safety And Efficacy ◽

Phase 1 Clinical Trial ◽

Pet Tracer

Download Full-text

A Study to Confirm Safety and Efficacy of BAN2401 in Participants With Early Alzheimer's Disease

Case Medical Research ◽

10.31525/ct1-nct03887455 ◽

2019 ◽

Author(s):

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Safety And Efficacy ◽

Early Alzheimer’S Disease

Download Full-text

Faculty Opinions recommendation of Effectiveness of head-mounted vibrotactile stimulation in subjects with bilateral vestibular loss: a phase 1 clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1164123.624796 ◽

2009 ◽

Author(s):

Joseph Furman ◽

Maha Tayseer Mohammad

Keyword(s):

Clinical Trial ◽

Phase 1 ◽

Vibrotactile Stimulation ◽

Vestibular Loss ◽

Phase 1 Clinical Trial ◽

Bilateral Vestibular Loss

Download Full-text